newsfilter
← Latest News
PR Newswire·

Liminal Biosciences to Present at H.C. Wainwright 24th Annual Global Investment Conference

LAVAL, QC and CAMBRIDGE, England, Aug. 29, 2022 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ:LMNL) ("Liminal BioSciences" or the "Company"), a development-stage biopharmaceutical company, announced that Bruce Pritchard, Chief Executive Officer at Limi